print-logo
Logo
  • Healthcare Consultants
  • Healthcare Managers
  • Who we are Arrow Down
    • About us
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Market Access
    • Medical Affairs
    • Government Affairs
    • Commercial Excellence
    • Patient Affairs
    • Healthcare Improvement
  • Insights Arrow Down
    • Publications
    • Project cases
    • Early Asset Strategy
    • Value Pull-through
    • Environment Transformation
  • Careers Arrow Down
    • Why join us
    • FAQ
  • Contact
  • Search Icon
  • Healthcare Consultants
  • Healthcare Managers
  • Search Icon
  • Search
Back to Our team

Anna Lenard

Manager | Zurich, CH

Bild von Anna Lenard

Contact

  • mail_icon a.lenard@executiveinsight.ch
  • linkedin_icon LinkedIn-Profile

Education

PhD in vascular cell biology from the Biozentrum, University of Basel, Master of Science and Engineer degree in Biotechnology from Warsaw University of Life Sciences

Languages

English, Polish

I used to work in a lab making transgenic fish glow in the dark.... I still like to follow science news, curious what the next big discovery might be!

Advances in gene therapy and the impact of CAR-T cell therapy for cancer patients
Publication

Advances in gene therapy and the impact of CAR-T cell therapy for cancer patients

Documenting barriers to access for a cell/gene therapy
Project Case

Documenting barriers to access for a cell/gene therapy

Cell therapy treating center management approach
Project Case

Cell therapy treating center management approach

Share this page
  • linkedin_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Contact
  • Terms of use
  • Privacy policy
  • Imprint

2025 Executive Insight. All rights reserved.